Prévalence < Prévention < Pseudoathétose

Facettes :

List of bibliographic references indexed by Prévention

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
001271 (2011)	Alessandra Nicoletti [Italie] ; Giovanni Mostile [Italie] ; Roberto Cappellani [Italie] ; Donatella Contrafatto [Italie] ; Gennarina Arabia [Italie] ; Paolo Lamberti [Italie] ; Roberto Marconi [Italie] ; Letterio Morgante [Italie] ; Paolo Barone [Italie] ; Aldo Quattrone [Italie] ; Mario Zappia [Italie]	Wine drinking and essential tremor: A possible protective role
002212 (2009)	Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie]	Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community
002B21 (2007)	Cara W. J. Verdellen [Pays-Bas] ; Cees A. L. Hoogduin [Pays-Bas] ; Ger P. J. Keijsers [Pays-Bas]	Tic suppression in the treatment of Tourette's syndrome with exposure therapy: The rebound phenomenon reconsidered
003245 (2006)	Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
003599 (2006)	Yoshihiro Sato [Japon] ; Jun Iwamoto [Japon] ; Tomohiro Kanoko [Japon] ; Kei Satoh [Japon]	Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial
003742 (2005)	Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]	Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
003B41 (2004)	Leonard A. Smith [États-Unis] ; Melody J. Jensen [États-Unis] ; Vicki A. Montgomery [États-Unis] ; Douglas R. Brown [États-Unis] ; S. Ashrat Ahmed [États-Unis] ; Theresa J. Smith [États-Unis]	Roads from vaccines to therapies
004155 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada]	Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys
004596 (2002)		Surgical treatment for Parkinson's disease: Deep brain surgery
004606 (2002)		MAO-B inhibitors for the treatment of Parkinson's disease
004627 (2002)		DA agonists: Non-Ergot derivatives: Ropinirole
004628 (2002)		DA agonists: Non-Ergot derivatives: Pramipexole
004631 (2002)		DA agonists: Ergot derivatives: Pergolide
004632 (2002)		DA agonists: Ergot derivatives: Lisuride
004633 (2002)		DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC)
004634 (2002)		DA agonists: Ergot derivatives: Cabergoline
004637 (2002)		COMT inhibitors
004641 (2002)		Amantadine and other antiglutamate agents
005486 (1997)	C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal]	Movement disorders cochrane collaborative review group
005795 (1996)
005A51 (1995)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Prévention" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Prévention" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Prévention
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024